CAR-T Cell Therapy
CAR-T细胞治疗
Duration
4-8 weeks (including monitoring)
Recovery
2-3 months for immune system recovery, 6-12 months for full monitoring
Savings
~79% vs US
Average savings compared to US prices
Chimeric Antigen Receptor T-cell (CAR-T) therapy is a revolutionary cancer immunotherapy that reprograms a patient's own immune cells to recognize and destroy cancer cells. China is a global leader in CAR-T research and clinical application, with multiple approved products and hundreds of ongoing clinical trials. Pricing in China varies significantly: $40,000-$80,000 for clinical trial access or hospital-manufactured (in-house) CAR-T products, while NMPA-approved commercial products (such as Yescarta/Relma-cel and Carteyva) cost $138,000-$180,000. Even at the commercial price, this represents major savings versus the US, where list prices for approved CAR-T products range from $370,000-$530,000. Chinese hospitals have treated thousands of patients with hematological cancers including leukemia, lymphoma, and multiple myeloma.
Eligibility Assessment & Case Review
The oncology team reviews the patient's complete medical history, pathology reports, imaging studies, and prior treatment records. Blood tests and bone marrow biopsy may be performed to confirm the diagnosis and assess eligibility. An international patient coordinator facilitates remote consultation before travel.
Duration: 1-2 weeks (can be done remotely)Leukapheresis (T-Cell Collection)
The patient's blood is drawn through a specialized machine (apheresis) that separates and collects T-cells while returning the remaining blood components. This typically takes several hours and is performed at the hospital's cell therapy center.
Duration: 3-5 hoursCAR-T Cell Manufacturing
The collected T-cells are sent to a GMP-certified laboratory where they are genetically modified to express chimeric antigen receptors targeting specific cancer markers (such as CD19 for B-cell cancers). The engineered cells are expanded to reach therapeutic numbers through careful cultivation.
Duration: 2-4 weeksLymphodepletion Chemotherapy
Before infusion, the patient undergoes a short course of lymphodepletion chemotherapy (typically fludarabine and cyclophosphamide) to suppress existing immune cells and create an optimal environment for the CAR-T cells to expand and function.
Duration: 3 daysCAR-T Cell Infusion
The engineered CAR-T cells are infused back into the patient through an intravenous line. The infusion itself is relatively quick, but patients are closely monitored in the hospital for 2-4 weeks for potential side effects including cytokine release syndrome (CRS) and neurotoxicity.
Duration: 30-60 minutes (infusion) + 2-4 weeks (monitoring)Post-Treatment Monitoring & Follow-Up
After discharge, patients remain near the hospital for 4-8 weeks of close monitoring with regular blood tests, imaging, and clinical assessments. Long-term follow-up continues for 6-12 months to track treatment response and manage any late side effects. Remote monitoring can be coordinated with the patient's home oncologist.
Duration: 6-12 months (ongoing)- Significant cost savings compared to the US ($40,000-$150,000 in China vs $370,000-$530,000 in the US)
- China has multiple approved CAR-T products and extensive clinical experience
- Access to novel CAR-T targets and clinical trials not available elsewhere
- High complete remission rates for eligible patients with blood cancers
- Experienced hematology teams at top hospitals like West China, Ruijin, and PUMCH
- Potential cure for patients who have exhausted other treatment options
- Cytokine release syndrome (CRS) — a potentially serious inflammatory response requiring ICU care
- Neurotoxicity (ICANS) — temporary neurological side effects
- Prolonged hospital stay required — patients must stay near the hospital for weeks
- Not all patients respond to treatment — efficacy depends on cancer type and stage
- Immune suppression during recovery increases infection risk
- Long travel distances for critically ill patients
- Requires comprehensive pre- and post-treatment coordination with home oncologist
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.